Literature DB >> 6992715

Efficacy of orally administered salbutamol and theophylline in pre-schoolchildren with asthma.

R C Groggins, W Lenney, A D Milner, G M Stokes.   

Abstract

Oral administration of salbutamol and theophylline has been shown to be effective in relieving bronchoconstriction in asthmatic children aged between 3 and 5 years. Changes in respiratory function were monitored using a Wright's low range peak flow meter and a modification of the forced oscillation technique. A combination of both drugs in half doses was as effective as either alone. Nebulised salbutamol produced considerable further improvement in lung function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6992715      PMCID: PMC1626748          DOI: 10.1136/adc.55.3.204

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Forced oscillation technique for determination of resistance to breathing in children.

Authors:  J J Cogswell
Journal:  Arch Dis Child       Date:  1973-04       Impact factor: 3.791

2.  Peak expiratory flow rates in children under 5 years of age.

Authors:  A D Milner; D Ingram
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

3.  Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study.

Authors:  H Williams; K N McNicol
Journal:  Br Med J       Date:  1969-11-08

4.  Continuous and intermittent salbutamol tablet administration in asthmatic children.

Authors:  W Lenney; A D Milner; E J Hiller
Journal:  Br J Dis Chest       Date:  1979-07

5.  Recurrent wheezing in the preschool child.

Authors:  W Lenney; A D Milner
Journal:  Arch Dis Child       Date:  1978-06       Impact factor: 3.791

6.  At what age do bronchodilator drugs work?

Authors:  W Lenney; A D Milner
Journal:  Arch Dis Child       Date:  1978-07       Impact factor: 3.791

7.  Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study.

Authors:  G Hambleton; M Weinberger; J Taylor; M Cavanaugh; E Ginchansky; S Godfrey; M Tooley; T Bell; S Greenberg
Journal:  Lancet       Date:  1977-02-19       Impact factor: 79.321

  7 in total
  12 in total

Review 1.  Oral xanthines as maintenance treatment for asthma in children.

Authors:  P Seddon; A Bara; F M Ducharme; T J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  Current state of theophylline in asthma.

Authors:  S McKenzie
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

3.  Response to bronchodilators assessed by lung mechanics.

Authors:  A Greenough; B G Loftus; J Pool; J F Price
Journal:  Arch Dis Child       Date:  1986-10       Impact factor: 3.791

Review 4.  Acute airways obstruction in children under 5.

Authors:  A D Milner; R L Henry
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

5.  Response to bronchodilator drugs in the first years of life.

Authors:  A D Milner
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

6.  Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone.

Authors:  G F Fox; M J Marsh; A D Milner
Journal:  Eur J Pediatr       Date:  1996-06       Impact factor: 3.183

Review 7.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

8.  Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma.

Authors:  G Lönnerholm; T Foucard; B Lindström
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-28

9.  Effects of oral theophylline and oral salbutamol in the treatment of asthma.

Authors:  K P Dawson; D M Fergusson
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

Review 10.  The use of anti-asthmatic drugs. Do they affect sports performance?

Authors:  K D Fitch
Journal:  Sports Med       Date:  1986 Mar-Apr       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.